+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Neuropathy Pain Treatment Market 2020-2024 - Product Image

Global Neuropathy Pain Treatment Market 2020-2024

  • ID: 5027240
  • Report
  • April 2020
  • Region: Global
  • 120 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca Plc
  • Baxter International Inc.
  • Eli Lilly and Co.
  • Endo International Plc
  • Johnson & Johnson
  • MORE
Global Neuropathy Pain Treatment Market 2020-2024

The neuropathy pain treatment market is poised to grow by $ 1702.89 mn during 2020-2024 progressing at a CAGR of 5% during the forecast period. The reports on neuropathy pain treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the presence of large patient pool and focus toward the development of novel therapeutics for postherpetic neuralgia.

The neuropathy pain treatment market analysis includes type segment and geographic landscape.

The neuropathy pain treatment market is segmented as below:

By Type
  • Diabetic neuropathy
  • Chemotherapy-induced neuropathy pain
  • Postherpetic neuralgia
  • Others
By Geographic Landscapes
  • North America
  • Europe
  • APAC
  • South America
  • MEA
This study identifies the growing focus on the development of drugs for the treatment of diabetic neuropathy pain as one of the prime reasons driving the neuropathy pain treatment market growth during the next few years.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. The neuropathy pain treatment market covers the following areas:
  • Neuropathy pain treatment market sizing
  • Neuropathy pain treatment market forecast
  • Neuropathy pain treatment market industry analysis.
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading neuropathy pain treatment market vendors that include Abbott Laboratories, Assertio Therapeutics Inc. , AstraZeneca Plc, Baxter International Inc., Eli Lilly and Co., Endo International Plc, Johnson & Johnson, Pfizer Inc., and Sanofi. Also, the neuropathy pain treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.

This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca Plc
  • Baxter International Inc.
  • Eli Lilly and Co.
  • Endo International Plc
  • Johnson & Johnson
  • MORE
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Indication
  • Market segments
  • Comparison by Indication
  • Diabetic neuropathy - Market size and forecast 2019-2024
  • Chemotherapy-induced neuropathy pain - Market size and forecast 2019-2024
  • Postherpetic neuralgia - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by indication
Market Segmentation by drug class
  • Calcium channel alpha 2-delta ligands
  • Serotonin-norepinephrine reuptake inhibitors (SNRIs)
  • TCAs
  • Opioid analgesics
  • Others
Customer landscape
  • Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Assertio Therapeutics Inc.
  • AstraZeneca Plc
  • Baxter International Inc.
  • Dr Reddy's Laboratories
  • Eli Lilly and Co.
  • Endo International Plc
  • Johnson & Johnson
  • Pfizer Inc.
  • Sanofi
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
List of Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2019 - 2024 ($ million)
13: Global market: Year-over-year growth 2019 - 2024 (%)
14: Five forces analysis 2019 & 2024
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2019
21: Other1 - Market share 2019-2024 (%)
22: Comparison by Other1
23: Diabetic neuropathy - Market size and forecast 2019-2024 ($ million)
24: Diabetic neuropathy - Year-over-year growth 2019-2024 (%)
25: Chemotherapy-induced neuropathy pain - Market size and forecast 2019-2024 ($ million)
26: Chemotherapy-induced neuropathy pain - Year-over-year growth 2019-2024 (%)
27: Postherpetic neuralgia - Market size and forecast 2019-2024 ($ million)
28: Postherpetic neuralgia - Year-over-year growth 2019-2024 (%)
29: Others - Market size and forecast 2019-2024 ($ million)
30: Others - Year-over-year growth 2019-2024 (%)
31: Market opportunity by Other1
32: Customer landscape
33: Market share by geography 2019-2024 (%)
34: Geographic comparison
35: North America - Market size and forecast 2019-2024 ($ million)
36: North America - Year-over-year growth 2019-2024 (%)
37: Europe - Market size and forecast 2019-2024 ($ million)
38: Europe - Year-over-year growth 2019-2024 (%)
39: APAC - Market size and forecast 2019-2024 ($ million)
40: APAC - Year-over-year growth 2019-2024 (%)
41: South America - Market size and forecast 2019-2024 ($ million)
42: South America - Year-over-year growth 2019-2024 (%)
43: MEA - Market size and forecast 2019-2024 ($ million)
44: MEA - Year-over-year growth 2019-2024 (%)
45: Key leading countries
46: Market opportunity by geography ($ million)
47: Impact of drivers and challenges
48: Vendor landscape
49: Landscape disruption
50: Industry risks
51: Vendors covered
52: Market positioning of vendors
53: Abbott Laboratories - Overview
54: Abbott Laboratories - Business segments
55: Abbott Laboratories - Key offerings
56: Abbott Laboratories - Key customers
57: Abbott Laboratories - Segment focus
58: Assertio Therapeutics Inc. - Overview
59: Assertio Therapeutics Inc. - Business segments
60: Assertio Therapeutics Inc. - Key offerings
61: Assertio Therapeutics Inc. - Key customers
62: Assertio Therapeutics Inc. - Segment focus
63: AstraZeneca Plc - Overview
64: AstraZeneca Plc - Business segments
65: AstraZeneca Plc - Key offerings
66: AstraZeneca Plc - Key customers
67: AstraZeneca Plc - Segment focus
68: Baxter International Inc. - Overview
69: Baxter International Inc. - Business segments
70: Baxter International Inc. - Key offerings
71: Baxter International Inc. - Key customers
72: Baxter International Inc. - Segment focus
73: Eli Lilly and Co. - Overview
74: Eli Lilly and Co. - Business segments
75: Eli Lilly and Co. - Key offerings
76: Eli Lilly and Co. - Key customers
77: Eli Lilly and Co. - Segment focus
78: Endo International Plc - Overview
79: Endo International Plc - Business segments
80: Endo International Plc - Key offerings
81: Endo International Plc - Key customers
82: Endo International Plc - Segment focus
83: Johnson & Johnson - Overview
84: Johnson & Johnson - Business segments
85: Johnson & Johnson - Key offerings
86: Johnson & Johnson - Key customers
87: Johnson & Johnson - Segment focus
88: Pfizer Inc. - Overview
89: Pfizer Inc. - Business segments
90: Pfizer Inc. - Key offerings
91: Pfizer Inc. - Key customers
92: Pfizer Inc. - Segment focus
93: Sanofi - Overview
94: Sanofi - Business segments
95: Sanofi - Key offerings
96: Sanofi - Key customers
97: Sanofi - Segment focus
98: Currency conversion rates for US$
99: Research Methodology
100: Validation techniques employed for market sizing
101: Information sources
102: List of abbreviations
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • AstraZeneca Plc
  • Baxter International Inc.
  • Eli Lilly and Co.
  • Endo International Plc
  • Johnson & Johnson
  • MORE
The publisher recognizes the following companies as the key players in the global neuropathy pain treatment market: Abbott Laboratories, Assertio Therapeutics Inc. , AstraZeneca Plc, Baxter International Inc., Eli Lilly and Co., Endo International Plc, Johnson & Johnson, Pfizer Inc., and Sanofi.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing focus on the development of drugs for the treatment of diabetic neuropathy pain."

According to the report, one of the major drivers for this market is the presence of large patient pool.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Abbott Laboratories
  • Assertio Therapeutics Inc.Â
  • AstraZeneca Plc
  • Baxter International Inc.
  • Eli Lilly and Co.
  • Endo International Plc
  • Johnson & Johnson
  • Pfizer Inc.
  • Sanofi
Note: Product cover images may vary from those shown
Adroll
adroll